Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Masahiro, Kodani"'
Autor:
Takeshi Masuda, Yukari Tsubata, Kojirou Hata, Mika Horie, Katsuyuki Kiura, Nobuhiro Kanaji, Takuya Inoue, Masahiro Kodani, Masaaki Yanai, Kakuhiro Yamaguchi, Naoko Matsumoto, Masahiro Yamasaki, Nobuhisa Ishikawa, Ken Masuda, Nagio Takigawa, Shoichi Kuyama, Tetsuya Kubota, Kazuya Nishii, Katsuyuki Hotta, Noboru Hattori
Publikováno v:
Thoracic Cancer, Vol 15, Iss 34, Pp 2408-2417 (2024)
Abstract Introduction Studies have shown the antitumor efficacy of immune checkpoint inhibitors (ICI) in patients with non‐small cell lung cancer (NSCLC) and brain metastases (BM). However, it is unclear whether the efficacy of ICI is similar betwe
Externí odkaz:
https://doaj.org/article/401e89a484174ad7967a9803e639b733
Autor:
Hideki Terai, MD, Kenzo Soejima, MD, Asanao Shimokawa, PhD, Hidehito Horinouchi, MD, Junichi Shimizu, MD, Tetsunari Hase, MD, Ryota Kanemaru, MD, Kana Watanabe, MD, Kiichiro Ninomiya, MD, Naoko Aragane, MD, Noriko Yanagitani, MD, Yoshihiko Sakata, MD, Masahiro Seike, MD, Daichi Fujimoto, MD, Masashi Kasajima, MD, Akihito Kubo, MD, Sojiro Kusumoto, MD, Yoshitaka Oyamada, MD, Keiichi Fujiwara, MD, Masahide Mori, MD, Midori Hashimoto, MD, Masato Shingyoji, MD, Masahiro Kodani, MD, Jin Sakamoto, MD, Toshihiko Agatsuma, MD, Kosuke Kashiwabara, MD, Minehiko Inomata, MD, Motoko Tachihara, MD, Kazuhisa Tanaka, MD, Kenji Hayashihara, MD, Nobuyuki Koyama, MD, Kaoru Matsui, MD, Koichi Minato, MD, Daisuke Jingu, MD, Hiroyuki Sakashita, MD, Satoshi Hara, MD, Tomoyuki Naito, MD, Asuka Okada, MD, Masayuki Tanahashi, MD, Yuki Sato, MD, Koichiro Asano, MD, Takayuki Takeda, MD, Kensuke Nakazawa, MD, Toshiyuki Harada, MD, Kazuhiko Shibata, MD, Tatsuo Kato, MD, Etsuo Miyaoka, PhD, Ichiro Yoshino, MD, Akihiko Gemma, MD, Tetsuya Mitsudomi, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 11, Pp 100404- (2022)
Introduction: Pembrolizumab is a programmed death-ligand 1 inhibitor that was initially indicated for monotherapy in patients with advanced lung cancer. The Japanese Lung Cancer Society conducted an observational study on pembrolizumab using confirma
Externí odkaz:
https://doaj.org/article/67a827674fcd4c4087dafceff77375be
Autor:
Kazuya Nishii, Masaaki Inoue, Hideto Obata, Yutaka Ueda, Toshiyuki Kozuki, Masahiro Yamasaki, Tomonori Moritaka, Yoshikazu Awaya, Keisuke Sugimoto, Kenichi Gemba, Shoichi Kuyama, Hirohisa Ichikawa, Takuo Shibayama, Tetsuya Kubota, Masahiro Kodani, Daizo Kishino, Nobukazu Fujimoto, Nobuhisa Ishikawa, Yukari Tsubata, Tomoya Ishii, Kazunori Fujitaka, Katsuyuki Hotta, Katsuyuki Kiura
Publikováno v:
Thoracic Cancer, Vol 12, Iss 5, Pp 725-731 (2021)
Abstract Introduction Conventional cancer registries are suitable for simple surveillance of cancer patients, including disease frequency and distribution, demographics, and prognosis; however, the collected data are inadequate to clarify comprehensi
Externí odkaz:
https://doaj.org/article/39cc5a45f0b247419b90dcc755431024
Autor:
Tomohiro Sakamoto, Akira Yamasaki, Yoshihiro Funaki, Tomoya Harada, Ryota Okazaki, Yasuyuki Hasegawa, Yuriko Sueda, Takehito Fukushima, Masahito Morita, Akihiro Yamamoto, Masahiro Kodani, Eiji Shimizu
Publikováno v:
Respiratory Medicine Case Reports, Vol 23, Iss , Pp 60-62 (2018)
A 62-year old man was admitted to our hospital with a 2-week complaint of a dry cough, general fatigue, and dyspnea on effort. He has been an onion farmer for several years and developed these symptoms after cleaning up onion peels with air compresso
Externí odkaz:
https://doaj.org/article/fab5a60a9bc74c7c9336609f4e6c14ad
Autor:
Takashi Ninomiya, Nobuhisa Ishikawa, Toshiyuki Kozuki, Shoichi Kuyama, Koji Inoue, Toshihide Yokoyama, Nobuhiro Kanaji, Masayuki Yasugi, Takuo Shibayama, Keisuke Aoe, Nobuaki Ochi, Kazunori Fujitaka, Masahiro Kodani, Yutaka Ueda, Kazuhiko Watanabe, Akihiro Bessho, Keisuke Sugimoto, Isao Oze, Katsuyuki Hotta, Katsuyuki Kiura
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8974f6eb0e2a0db9f7f02436ab3f51bb
https://doi.org/10.2139/ssrn.4416280
https://doi.org/10.2139/ssrn.4416280
Autor:
Kaname Nosaki, Jun Sakakibara-Konishi, Ichiro Nakachi, Yoshitaka Zenke, Kageaki Taima, Keisuke Kirita, Kiyotaka Yoh, Shunta Mori, Genichiro Ishii, Shoichi Kuyama, Tatsuro Fukuhara, Shingo Matsumoto, Shogo Kumagai, Hiroki Izumi, Yuji Shibata, Seiji Niho, Noriyuki Ebi, Takaya Ikeda, Jie Liu, Tokiko Nakai, Masahiro Kodani, Haruko Daga, Terufumi Kato, Tetsuya Sakai, Koichi Goto, Atsushi Ohtsu, Kosuke Tanaka, Eri Sugiyama, Atsushi Nakamura, Kana Watanabe, Takuma Hayashida, Isamu Okamoto, Susumu Kobayashi, Kazumi Nishino, Kumiko Hayashi, Naoki Furuya, Hibiki Udagawa, Akira Yamasaki
Publikováno v:
Nature. 600:319-323
Lung cancer is one of the most aggressive tumour types. Targeted therapies stratified by oncogenic drivers have substantially improved therapeutic outcomes in patients with non-small-cell lung cancer (NSCLC)1. However, such oncogenic drivers are not
Autor:
Yutaka Ueda, Masaaki Inoue, Nobuhisa Ishikawa, Hideto Obata, Masahiro Kodani, Shoichi Kuyama, Kazuya Nishii, Takuo Shibayama, Katsuyuki Hotta, Tetsuya Kubota, Tomoya Ishii, Kazunori Fujitaka, Hirohisa Ichikawa, Nobukazu Fujimoto, Masahiro Yamasaki, Yukari Tsubata, Daizo Kishino, Yoshikazu Awaya, Toshiyuki Kozuki, Tomonori Moritaka, Keisuke Sugimoto, Kenichi Gemba, Katsuyuki Kiura
Publikováno v:
Thoracic Cancer, Vol 12, Iss 5, Pp 725-731 (2021)
Thoracic Cancer
Thoracic Cancer
Introduction Conventional cancer registries are suitable for simple surveillance of cancer patients, including disease frequency and distribution, demographics, and prognosis; however, the collected data are inadequate to clarify comprehensively dive
Autor:
Genki Inui, Yoshihiro Funaki, Haruhiko Makino, Hirokazu Touge, Katsunori Arai, Keisuke Kuroda, Yuuki Hirayama, Ryohei Kato, Takafumi Nonaka, Kohei Yamane, Yasuhiko Teruya, Yuriko Sueda, Tomohiro Sakamoto, Kosuke Yamaguchi, Masahiro Kodani, Shinya Kawase, Yoshihisa Umekita, Yasushi Horie, Kanae Nosaka, Akira Yamasaki
Publikováno v:
Molecular and Clinical Oncology. 17
Autor:
Shun Lu, Yongfeng Yu, Jianya Zhou, Koichi Goto, Xingya Li, Jun Sakakibara-Konishi, Kazumi Nishino, Tanaka Kentaro, Lin Wu, Xuhong Min, Wei Zhang, Dingzhi Huang, Yongqian Shu, Chengzhi Zhou, Min Li, Xiaorong Dong, Chong Bai, Lu Li, Jiuwei Cui, Li Zhang, Lejie Cao, Xiaoling Li, AiMin Zang, Haruki Kobayashi, Yiping Zhang, Yan Yu, Xiuwen Wang, Terufumi Kato, Shoichiro Yamamoto, Yuki Shinno, Xiaoyan Lin, Yanqiu Zhao, Yanping Hu, Qitao Yu, Ziping Wang, Masahiro Kodani, Jian Fang, Jialei Wang, Meiqi Shi, Diansheng Zhong, Wen Dong, Hiroshi Tanaka, Yasuto Yoneshima, Minghui Sun, Jun Zhou, Qiuxia Wu, Meng Li
Publikováno v:
Cancer Research. 82:CT034-CT034
Background: METex14 mutations was reported in 3~4% of NSCLC patients and became a new target in the treatment of NSCLC. SCC244 is a highly selective and potent oral MET inhibitor. This is the first report of data from an ongoing single-arm phase II s
Autor:
Naoto Burioka, Yasushi Fukuoka, Miyako Takata, Masahiro Endo, Masanori Miyata, Hiroki Chikumi, Katsuyuki Tomita, Masahiro Kodani, Hirokazu Touge, Kenichi Takeda, Takashi Sumikawa, Kousuke Yamaguchi, Yasuto Ueda, Hirofumi Nakazaki, Hisashi Suyama, Akira Yamasaki, Hiroyuki Sano, Tadashi Igishi, Eiji Shimizu
Publikováno v:
Journal of Pharmacological Sciences, Vol 103, Iss 2, Pp 144-149 (2007)
Bronchial asthma is a chronic inflammatory disorder of the airways, in which inflammation causes bronchial hyper-responsiveness and flow limitation in the presence of various stimuli. Pulmonary function in asthmatic patients frequently deteriorates b
Externí odkaz:
https://doaj.org/article/f15603b385124191aadb3e6be0f9a8bc